Concentrix Corp Files 8-K on Operations and Financials
Ticker: CNXC · Form: 8-K · Filed: Sep 25, 2024 · CIK: 1803599
| Field | Detail |
|---|---|
| Company | Concentrix CORP (CNXC) |
| Form Type | 8-K |
| Filed Date | Sep 25, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting
Related Tickers: CNXC
TL;DR
CNXC filed an 8-K for financial updates, check for details.
AI Summary
On September 25, 2024, Concentrix Corporation filed an 8-K report to disclose information regarding its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing signals that Concentrix Corporation is providing updated information to the SEC regarding its financial performance and condition, which is crucial for investors to assess the company's health.
Risk Assessment
Risk Level: low — The filing is a standard procedural report and does not contain information that inherently increases risk.
Key Players & Entities
- Concentrix Corporation (company) — Registrant
- September 25, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 39899 Balentine Drive (address) — Principal executive offices
- Newark, California (location) — City and State of principal executive offices
FAQ
What specific financial information is being reported in this 8-K?
The provided text indicates the filing is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific figures within this excerpt.
When was this 8-K report filed?
The report was filed on September 25, 2024.
What is Concentrix Corporation's state of incorporation?
Concentrix Corporation is incorporated in Delaware.
What is the address of Concentrix Corporation's principal executive offices?
The address is 39899 Balentine Drive, Suite 235, Newark, California 94560.
What is the purpose of an 8-K filing?
An 8-K filing is used to report significant events that shareholders should be aware of, such as changes in financial condition or operations.
Filing Stats: 516 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-09-25 16:08:57
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share CNXC The Nasdaq Stock Market
Filing Documents
- cnxc-20240925.htm (8-K) — 26KB
- exhibit991q32024.htm (EX-99.1) — 382KB
- concentrixlogo.jpg (GRAPHIC) — 57KB
- 0001803599-24-000150.txt ( ) — 638KB
- cnxc-20240925.xsd (EX-101.SCH) — 2KB
- cnxc-20240925_lab.xml (EX-101.LAB) — 22KB
- cnxc-20240925_pre.xml (EX-101.PRE) — 13KB
- cnxc-20240925_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On September 25, 2024, Concentrix Corporation (the "Company" or "Concentrix") issued a press release reporting its financial results for the third quarter ended August 31, 2024. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated in this Item 2.02 by reference. The information contained in this Current Report on Form 8-K is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference into any Concentrix filing or report with the Securities and Exchange Commission, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing or report.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by Concentrix Corporation on September 25, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 25, 2024 CONCENTRIX CORPORATION By: /s/ Andre Valentine Andre Valentine Chief Financial Officer